Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NSC 67657

Known as: NSC-67657, NSC67657 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
NSC67657 is a new steroid drug that induces monocytic differentiation of acute myeloid leukemia cells. Here, we demonstrate that… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
NSC67657 is a new steroid drug that induces monocytic differentiation of acute myeloid leukemia cells. Here, we demonstrate that… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
OBJECTIVE To investigate the expression of mRNA and proteins of β-catenin, TCF-4 (ICAT) and Wnt signaling pathway-related genes… Expand
Is this relevant?
2013
2013
To verify the differential expression of non-metastasis cell 3 (NME3) protein in HL-60 cells when they were induced to… Expand
Is this relevant?
2010
2010
OBJECTIVE To study the potential mechanism of the new steroidal drug NSC67657 induced leukemic cells differentiation. METHODS… Expand
Is this relevant?
2009
2009
BACKGROUND AND OBJECTIVE Human promyelocytic leukemia cell line HL-60 has potential to differentiate into granulocytes and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2009
2009
A novel sterol mesylate compound (NSC67657) was recently identified and reported by National Cancer Institute that could… Expand
Is this relevant?